Tavus vs Abridge

Side-by-side comparison of AI visibility scores, market position, and capabilities

AI visibility is closely matched (38 vs 41)
Tavus logo

Tavus

EmergingConsumer Technology

General

SF YC generative AI personalized video at $24.2M total ($18M Scale Venture Partners Series A Mar 2024) serving Salesforce and Meta;

AI VisibilityBeta
Overall Score
D38
Category Rank
#747 of 1158
AI Consensus
68%
Trend
up
Per Platform
ChatGPT
33
Perplexity
32
Gemini
37

About

Tavus is a San Francisco-based generative AI personalized video platform — backed by Y Combinator with $24.2 million in total funding including an $18 million Series A in March 2024 led by Scale Venture Partners with a $6.1 million seed led by Sequoia Capital — providing enterprises, sales teams, and developers with APIs and SaaS tools for creating hyper-personalized AI videos at scale using voice and face cloning technology, serving major customers including Salesforce and Meta with 49 employees. Founded in 2020, Tavus's proprietary Phoenix model requires only 2 minutes of video training data to clone a person's voice, facial movements, and speaking style — enabling the creation of thousands of fully personalized video messages from a single human recording session, with each video appearing as if filmed specifically for each individual recipient.

Full profile
Abridge logo

Abridge

EmergingHealthcare

General

Pittsburgh ambient clinical AI (founded by cardiologist) at $5.3B valuation Jun 2025; $800M total ($300M a16z/Khosla Series E) deployed at UPMC 12K clinicians, Mayo Clinic, Johns Hopkins competing with Nuance DAX for physician documentation.

AI VisibilityBeta
Overall Score
C41
Category Rank
#777 of 1158
AI Consensus
50%
Trend
up
Per Platform
ChatGPT
35
Perplexity
49
Gemini
33

About

Abridge is a Pittsburgh, Pennsylvania-based healthcare AI clinical documentation platform — backed with approximately $800 million in total funding including a $300 million Series E in June 2025 led by Andreessen Horowitz and Khosla Ventures at a $5.3 billion valuation, following a $250 million Series D just four months prior at a $2.8 billion valuation — providing physicians, nurses, and care teams at 150+ health systems with AI that automatically converts patient-clinician conversations into structured clinical notes, saving physicians an average of 3 hours daily and generating high-quality documentation from UPMC (scaling to 12,000 clinicians enterprise-wide), Mayo Clinic, Johns Hopkins, and Emory Healthcare. Abridge's AI is trained on a proprietary dataset of over 1.5 million medical encounters, delivering specialty-specific documentation through deep Epic EHR integration. Founded in 2018 by cardiologist Dr. Shiv Rao.

Full profile

AI Visibility Head-to-Head

38
Overall Score
41
#747
Category Rank
#777
68
AI Consensus
50
up
Trend
up
33
ChatGPT
35
32
Perplexity
49
37
Gemini
33
40
Claude
51
45
Grok
38

Key Details

Category
General
General
Tier
Emerging
Emerging
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.